Boothwyn Pharmacy LLC

FDA Regulatory Profile

Boothwyn Pharmacy LLC appears in FDA public data with 4 recalls, 0 510(k) clearances, 4 FDA inspections, and 3 compliance actions on record. Its most recent recall (D-0607-2025, Class III) was initiated on July 9, 2025.

Summary

Total Recalls
4
510(k) Clearances
0
Inspections
4
Compliance Actions
3

Recent Recalls

NumberClassProductDate
D-0607-2025Class IIIFluorescein 2% Ophth, 3 ML, Boothwyn Pharmacy, 800-476-7496July 9, 2025
D-0609-2025Class IISemaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn PharmacyJuly 9, 2025
D-0608-2025Class IISemaglutide, 2.5 mg/mL injection, 0.8 mL, Boothwyn PharmacyJuly 9, 2025
D-0606-2025Class IISemaglutide, 2.5 mg/mL injection, 2 mL., Boothwyn PharmacyJuly 9, 2025